clinicaltrialsarena41m
Viking reports data from X-linked adrenoleukodystrophy trial
Viking Therapeutics has announced positive results from its Phase Ib trial of VK0214 in patients with X-linked ...
clinicaltrialsarena2h
Vanqua’s Parkinson’s drug shows promise as company initiates Phase Ib study
Chicago-based Vanqua Bio’s Parkinson’s disease drug has shown proof-of-concept in a first-in-human study, with the company to ...
clinicaltrialsarena3h
Priovant mulls broad autoimmune indications for brepacitinib
Priovant expects topline data from two Phase III trials for its dual TYK2 and Jak1 inhibitor in dermatomyositis and uveitis ...
clinicaltrialsarena4h
InnoCare’s Phase II psoriasis therapy trial meets primary endpoint
InnoCare Pharma has announced that its Phase II study of the TYK2 inhibitor ICP-488 for psoriasis treatment met the primary ...
clinicaltrialsarena5h
DiaMedica gets SAHPRA approval for Phase II preeclampsia treatment trial
DiaMedica Therapeutics has received the SAHPRA approval to commence a Phase II trial of DM199 to treat preeclampsia.
clinicaltrialsarena19h
Gamification could help improve patient retention and engagement in clinical trials
Gamifying clinical trials could motivate participants to engage better with trial platforms and advance research.
clinicaltrialsarena23h
Allurion’s swallowable balloon hits trial success amid weakening financials
Allurion has added more efficacy and safety data to support its intragastric balloon, but popularity of GLP-1 drugs shows no ...